Analyst firms · Citigroup · GKOS
Citigroup GKOS price target and rating history
Glaukos Corporation (GKOS) · Health Care
Citigroup rates Glaukos Corporation (GKOS) Buy with a $162 price target, as of its latest action on Dec 11, 2024. It has published 4 rating actions on GKOS since February 2022, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $162
- Median target, all firms
- Too few
- Actions on GKOS
- 4
Citigroup price target on GKOS
Every Citigroup rating on GKOS
- Dec 11, 2024
- Jul 10, 2024
- Dec 12, 2022
- Feb 23, 2022
How other firms rate GKOS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | Jul 28, 2026 | |
| H.C. Wainwright | Buy | $168 | Jul 6, 2026 |
Questions about Citigroup and GKOS
- What is Citigroup's price target for GKOS?
- Citigroup's latest stated price target for Glaukos Corporation (GKOS) is $162, from its action on Dec 11, 2024.
- What is Citigroup's rating on GKOS?
- Citigroup rates GKOS Buy, a bullish rating, as of Dec 11, 2024.
- When did Citigroup last change its view on GKOS?
- On Dec 11, 2024, Citigroup upgrades to Buy from Neutral, price target $132 to $162.
More GKOS rating histories
All Citigroup ratingsGKOS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.